Oncology (all articles)
Caring for Patients with Cancer in the COVID-19 Era
17 Apr, 2020 | 02:07h | UTCCaring for patients with cancer in the COVID-19 era – Nature Medicine
Commentary: Caring for cancer patients in the COVID-19 era – Netherlands Cancer Institute
Related: NCCN Guidance: How to Keep our Oncology Patients and Healthcare Workers Safe AND ASCO Recommendations for the Oncology Community During the COVID19 Pandemic AND COVID-19 rapid guideline: delivery of systemic anticancer treatments – NICE AND COVID-19 rapid guideline: delivery of radiotherapy – NICE
Meta-Analysis: Aspirin and the Risk of Colorectal and Other Digestive Tract Cancers
17 Apr, 2020 | 01:54h | UTCNews Release: Aspirin linked to reduction in risk of several cancers of the digestive tract – European Society of Medical Oncology
ASCO Recommendations for the Oncology Community During the COVID19 Pandemic
16 Apr, 2020 | 02:41h | UTC
NCCN Guideline: Breast Cancer
16 Apr, 2020 | 02:31h | UTC
Guidelines for the Management of Hereditary Colorectal Cancer
16 Apr, 2020 | 02:28h | UTC
NCCN Guidance: How to Keep our Oncology Patients and Healthcare Workers Safe
10 Apr, 2020 | 03:17h | UTCNews Release: JNCCN: Improving COVID-19 safety for cancer patients and healthcare providers – National Comprehensive Cancer Network
ASCO Guideline: Management of Hereditary Breast Cancer
7 Apr, 2020 | 04:09h | UTC
ASCO Guideline: Systemic Therapy for Melanoma
3 Apr, 2020 | 03:57h | UTCSystemic Therapy for Melanoma: ASCO Guideline – Journal of Clinical Oncology
Study Evaluates Sensitivity and Specificity of New Multi-Cancer Detection Test
2 Apr, 2020 | 03:56h | UTC
The Lancet Commission: Sustainable Care for Children with Cancer
1 Apr, 2020 | 05:37h | UTCSustainable care for children with cancer – The Lancet Oncology (free articles – registration required)
A War on Two Fronts: Cancer Care in the Time of COVID-19
30 Mar, 2020 | 01:51h | UTCA War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine
Related Guidelines: COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence AND Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network
#ACC20 – [Abstract Only] Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
30 Mar, 2020 | 01:12h | UTCApixaban for the Treatment of Venous Thromboembolism Associated with Cancer – New England Journal of Medicine (abstract Only – $ for full-text)
Commentaries: Caravaggio Trial: Apixaban Noninferior to Dalteparin in Treatment of Cancer-Associated VTE – American College of Cardiology (free) AND Apixaban, Dalteprin Shown to Have Same Bleeding Risk in Patients With Cancer – AJMC (free)
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)
ESMO Guideline: Cancer-related Fatigue
27 Mar, 2020 | 03:34h | UTCCommentary: ESMO updates cancer-related fatigue recommendations – Medicine Matters (free)
[Abstract Only] Study: Global Incidence Trends in Primary Liver Cancer by Age at Diagnosis, Sex, Region, and Etiology
27 Mar, 2020 | 03:32h | UTCGlobal incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017 – Cancer (link to abstract – $ for full-text)
Commentary: Liver cancer incidence in older adults up 50% globally since 1990 – UPI
Cohort Study: Risk of Colorectal Cancer Incidence and Mortality after Polypectomy
25 Mar, 2020 | 01:57h | UTCCommentaries: Polyps and Colorectal Cancer risk – Karolinska Institutet (free) AND Risk of colorectal cancer incidence and mortality after polypectomy – ESMO (free)
NICE COVID-19 Rapid Guideline: Delivery of Systemic Anticancer Treatments
23 Mar, 2020 | 01:24h | UTCSee also: COVID-19: Updates for Oncologists & Hematologists (free resources)
COVID-19: Updates for Oncologists & Hematologists
25 May, 2020 | 00:01h | UTCOncology Guidelines
- Cancer Patient Management During the Covid-19 Pandemic – European Society of Medical Oncology
- Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic – Otolaryngology–Head and Neck Surgery (05/2020)
- Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk – JCO Oncology Practice (05/2020)
- Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report – Journal of the American College of Radiology (05/2020)
- A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises – Radiotherapy and Oncology (05/2020)
Oncology Articles
- Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic – The Lancet Oncology (05/2020)
- Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations – Annals of Surgical Oncology (05/2020)
- To Do or Not to Do?—A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic – Indian Journal of Surgical Oncology (05/2020)
- COVID-19 and Cancer: a Comprehensive Review – Current Oncology Reports (05/2020)
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARSCoV-2: a population-based study (n=4532) – Annals of Oncology (05/2020)
- Palliative Care for Patients With Cancer in the COVID-19 Era – JAMA Oncology (05/2020)
- Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan – The Lancet Oncology (05/2020)
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence – Critical Reviews in Oncology/Hematology (05/2020)
- Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases – Leukemia (05/2020)
- Bracing for impact with new 4R’s in the COVID-19 pandemic- a provincial thoracic radiation oncology consensus – Radiotherapy and Oncology (05/2020)
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak – Cancer Discovery AND Commentaries: COVID-19 Increases Overall Risk of Death, Complications in Patients With Cancer, Study Shows – AJMC AND Patients with blood and lung cancers are three times more at risk of dying of coronavirus than people with other tumors, study finds – Daily Mail AND Coronavirus: Cancer patients nearly three times more likely to die of Covid-19, study says – Independent (05/2020)
- Cancer Management in India during Covid-19 – New England Journal of Medicine (05/2020)
- COVID-19 in persons with haematological cancers – Leukemia (05/2020)
Hematologic Guidelines
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 – Journal of the American College of Cardiology
- Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID‐19 pandemic – British Journal of Haematology (05/2020)
- Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands – Radiology (05/2020)
- Patient blood management during the COVID‐19 pandemic ‐ a narrative review – Anaesthesia (05/2020)
Hematology Articles
- NEW – Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum – Journal of Thrombosis and Thrombolysis (05/2020)
- NEW – Thromboprophylaxis for medical inpatients with COVID-19 – Clinical Microbiology and Infection (05/2020)
- NEW – COVID-19 and coagulative axis: review of emerging aspects in a novel disease – Monaldi Archives for Chest Disease (05/2020)
- Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet (05/2020)
- Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 – Intensive Care Medicine (05/2020)
- Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine (05/2020)
- Care of Patients with Hemoglobin Disorders during the COVID-19 Pandemic: An Overview of Recommendations – American Journal of Hematology (05/2020)
- COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review – Critical Care (05/2020)
- Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis – International Journal of Infectious Diseases (05/2020)
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study – Intensive Care Medicine (05/2020)
- Coronavirus blood-clot mystery intensifies – Nature (05/2020)
- Arterial thromboembolic complications in COVID‐19 in low risk patients despite prophylaxis – British Journal of Haematology (05/2020)
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study – Annal of Internal Medicine (05/2020)
- Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 – The Lancet (05/2020)
- Coagulopathy associated with COVID-19 – Canadian Medical Association Journal (05/2020)
- Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge – Thrombosis and Haemostasis (05/2020)
- Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? – Thrombosis and Haemostasis (05/2020)
- The resurgence of convalescent plasma therapy – The Lancet Haematology (05/2020)
- COVID-19 and its implications for thrombosis and anticoagulation – Blood (05/2020)
Guidelines:
- Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis (04/2020)
- Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID19 Pandemic – American Society of Medical Oncology AND Commentary: ASCO Releases New Guidance on Allocation of Limited Resources in the Oncology Community During COVID-19 Pandemic – The ASCO Post (04/2020)
- Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19 – Thrombosis UK (04/2020)
- ISTH interim guidance on recognition and management of coagulopathy – Journal of Thrombosis and Haemostasis (04/2020)
- Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe – Journal of the National Comprehensive Cancer Network AND News Release: JNCCN: Improving COVID-19 safety for cancer patients and healthcare providers – National Comprehensive Cancer Network (04/2020)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement – Radiotherapy and Oncology (04/2020)
- Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic – FRANCOGYN group for the CNGOF – Journal of Gynecology Obstetrics and Human Reproduction (04/2020)
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group – The Oncologist (04/2020)
- COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence (03/2020)
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network (03/2020)
Articles:
- COVID‐19 Infection in Patients with Sickle Cell Disease – British Journal of Haematology (04/2020)
- COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis – JCO Global Oncology AND Commentaries: Meta-analysis highlights COVID-19 risk in cancer patients, survivors – Medicine Matters (04/2020)
- Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology (04/2020)
- COVID-19: impact on cancer workforce and delivery of care – The Lancet Oncology (04/2020)
- Caring for our cancer patients in the wake of COVID-19 – British Journal of Cancer (04/2020)
- D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 – Journal of Thrombosis and Haemostasis (04/2020)
- Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19 – Journal of Thrombosis and Haemostasis (04/2020)
- Caring for patients with cancer in the COVID-19 era – Nature Medicine AND Commentary: Caring for cancer patients in the COVID-19 era – Netherlands Cancer Institute (04/2020)
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up – Journal of the American College of Cardiology AND Commentary: JACC Paper Outlines Implications, Considerations For Thrombotic Disease Patients During COVID-19 Pandemic – American College of Cardiology (04/2020)
- The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer – JACC CardioOncology (04/2020)
- Hematological findings and complications of COVID‐19 – American Journal of Hematology (04/2020)
- COVID-19 and Coagulopathy: Frequently Asked Questions – American Society of Hematology (04/2020)
- Immune Thrombocytopenic Purpura in a Patient with Covid-19 – New England Journal of Medicine (04/2020)
- Oncology Practice During the COVID-19 Pandemic – JAMA (04/2020)
- D-dimer cutoffs to predict thrombosis in COVID-19 – PulmCrit (04/2020)
- Caring for Patients With Cancer During the COVID-19 Outbreak in Italy – JAMA Oncology (04/2020)
- Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic – Journal of Visceral Surgery (04/2020)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments – Radiation Oncology (04/2020)
- Testing the association between blood type and COVID-19 infection, intubation, and death – medRxiv (04/2020)
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 – New England Journal of Medicine (04/2020)
- How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere – ESMO Open (04/2020)
- Cancer guidelines during the COVID-19 pandemic – The Lancet Oncology (04/2020)
- D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis – Thrombosis and Haemostasis (04/2020)
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy – Journal of Thrombosis and Haemostasis (04/2020)
- Q & A: COVID-19 and Coagulopathy: Frequently Asked Questions – American Society of Hematology (04/2020)
- Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China – Annals of Oncology (04/2020)
- A War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine (03/2020)
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis – Clinica Chimica Acta (03/2020)
- Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia – Journal of Thrombosis and Haemostasia
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China – JAMA Oncology AND Commentary: Cancer linked to increased COVID-19 risk – MedwireNews (03/2020)
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China – The Lancet Oncology AND Commentaries: Risk of COVID-19 for patients with cancer – The Lancet Oncology AND Risk of COVID-19 for cancer patients – The Lancet Oncology (03/2020)
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infection – Clinical Chemistry and Laboratory Medicine (03/2020)
- Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection – Pediatric Blood & Cancer (03/2020)
- Risk of COVID-19 for patients with cancer – The Lancet Oncology (03/2020)
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis – Clinica Chimica Acta
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network (03/2020)
- How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat? – British Journal of Haematology (03/2020)
News & Perspectives:
- The Blind Leading the Blind: COVID-19, Cancer, and the Need for More Data – ASCO Daily News (03/2020)
- Mitigating the Spread of COVID-19 and Its Impact on Cancer: How Cancer Centers Are Preparing for the Coronavirus – The ASCO Post (03/2020)
- The Treatment of Patients With Cancer and Containment of COVID-19: Experiences From Italy – ASCO Daily News (03/2020)
- Coronavirus means difficult, life-changing decisions for me and my cancer patients – The Guardian (03/2020)
COVID-19 Hemato-Oncology: This page will be updated as often as necessary and will be fixed in the right column on our homepage.
Treatment of Patients with Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
23 Mar, 2020 | 00:50h | UTCCommentary: ASCO Releases Resource-Stratified Guideline on the Treatment of Late-Stage Colorectal Cancer – ASCO Daily News (free)
Guideline: The Palliative Care of Patients with Incurable Cancer
16 Mar, 2020 | 07:42h | UTCThe Palliative Care of Patients with Incurable Cancer – Deutsches Ärzteblatt international (free)
[Abstract Only] Meta-analysis of Randomized trials: Omega-3 Fats do not Protect Against Cancer
13 Mar, 2020 | 07:51h | UTCOmega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials – British Journal of Cancer (link to abstract – $ for full-text)
Commentary: Omega-3 fats do not protect against cancer – University of East Anglia (free)
[Abstract Only] Observational Study: Use of Low-dose Aspirin Linked to Lower Risk of Hepatocellular Carcinoma and Liver-related Mortality
12 Mar, 2020 | 08:19h | UTCAssociation of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Aspirin Use Associated with Reduced Hepatocellular Carcinoma and Liver-Related Mortality – NEJM Journal Watch (free)
Estimation of the Percentage of Patients with Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs
11 Mar, 2020 | 08:17h | UTC
[Abstract Only] Randomized Trial: Hippocampal Avoidance During Whole-Brain Radiotherapy for Patients with Brain Metastases
10 Mar, 2020 | 10:17h | UTCHippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentaries: Hippocampal avoidance during WBRT reduces risks on NRG Oncology trial – NRG Oncology (free) AND ‘Practice-Changing’ Study on WBRT for Patients With Brain Mets – Medscape (free registration required)
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities
8 Mar, 2020 | 20:19h | UTCRelated Guidelines: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (free) AND Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (free)
Related Reviews: A review of cancer immunotherapy toxicity – CA: A Cancer Journal for Clinicians (free) AND Immune Checkpoint Inhibitor Toxicities – Mayo Clinic Proceedings (free) AND New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management – Critical Care (free) AND Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know? – Annals of Intensive Care (free) AND Checkpoint Inhibitors: The diagnosis and treatment of side effects – Deutsches Ärzteblatt international (free)
[Abstract Only] Randomized Trial: Pembrolizumab for Early Triple-Negative Breast Cancer
8 Mar, 2020 | 20:17h | UTCPembrolizumab for Early Triple-Negative Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Neoadjuvant and Adjuvant Pembrolizumab in Early Triple-Negative Breast Cancer – ASCO Post (free)